Read how the “Ken Griffin Alpha-Synuclein Imaging Competition”, a $10-million program, funded in part by a leadership gift of $7.5 million from Ken Griffin, holds potential to transform Parkinson’s drug development. Also, learn more about new treatment options for people living with Parkinson’s disease and how diversity and inclusivity in PD research will offer a more holistic view of the disease. More
